Why is Shilpa Medicare falling/rising?

As of 19-Nov, Shilpa Medicare Ltd is experiencing a decline in its stock price, currently at Rs 360.00, which reflects a decrease of Rs 5.85 or 1.6%. The stock has been underperforming, having fallen consecutively for the last five days, resulting in a total decline of 9.92% over that period. Today's trading saw the stock hit an intraday low of Rs 351.8, and it is currently trading below all its moving averages. Additionally, investor participation has decreased significantly, with delivery volume dropping by 57.17% compared to the five-day average. Despite positive financial results over the last nine quarters, including a substantial increase in profits, the stock has underperformed with a year-to-date return of -11.44% and a one-year return of -18.17%, indicating a disconnect between its strong earnings growth and stock performance.
In the broader market context, Shilpa Medicare's performance contrasts sharply with the Sensex, which has gained 0.85% over the past week and 9.02% year-to-date. The stock's negative returns over the past year highlight its struggle against a backdrop of a generally rising market. While the company has shown strong operational metrics, such as a high return on capital employed and significant profit growth, its long-term growth prospects appear weak, with average annual sales growth of only 6.95% over the last five years. This combination of poor short-term performance relative to the market and weak long-term fundamentals contributes to the stock's current downward trajectory.